These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16954725)

  • 1. Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome.
    Fitch KV; Anderson EJ; Hubbard JL; Carpenter SJ; Waddell WR; Caliendo AM; Grinspoon SK
    AIDS; 2006 Sep; 20(14):1843-50. PubMed ID: 16954725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome.
    Lien LF; Brown AJ; Ard JD; Loria C; Erlinger TP; Feldstein AC; Lin PH; Champagne CM; King AC; McGuire HL; Stevens VJ; Brantley PJ; Harsha DW; McBurnie MA; Appel LJ; Svetkey LP
    Hypertension; 2007 Oct; 50(4):609-16. PubMed ID: 17698724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).
    Mohan V; Deepa R; Pradeepa R; Vimaleswaran KS; Mohan A; Velmurugan K; Radha V
    Metabolism; 2005 Apr; 54(4):476-81. PubMed ID: 15798954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial.
    Roshan H; Nikpayam O; Sedaghat M; Sohrab G
    Br J Nutr; 2018 Feb; 119(3):250-258. PubMed ID: 29307310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
    Hadigan C; Meigs JB; Corcoran C; Rietschel P; Piecuch S; Basgoz N; Davis B; Sax P; Stanley T; Wilson PW; D'Agostino RB; Grinspoon S
    Clin Infect Dis; 2001 Jan; 32(1):130-9. PubMed ID: 11118392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006.
    DeBoer MD; Gurka MJ
    Metab Syndr Relat Disord; 2010 Aug; 8(4):343-53. PubMed ID: 20698802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive lifestyle intervention improves cardiometabolic and exercise parameters in metabolically healthy obese and metabolically unhealthy obese individuals.
    Dalzill C; Nigam A; Juneau M; Guilbeault V; Latour E; Mauriège P; Gayda M
    Can J Cardiol; 2014 Apr; 30(4):434-40. PubMed ID: 24561010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yoga lifestyle intervention reduces blood pressure in HIV-infected adults with cardiovascular disease risk factors.
    Cade WT; Reeds DN; Mondy KE; Overton ET; Grassino J; Tucker S; Bopp C; Laciny E; Hubert S; Lassa-Claxton S; Yarasheski KE
    HIV Med; 2010 Jul; 11(6):379-88. PubMed ID: 20059570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in metabolic syndrome and its components with lifestyle modification in Japanese men.
    Miyatake N; Fujii M; Miyachi M; Tabata I; Takeshi S; Hirao T; Numata T
    Intern Med; 2010; 49(4):261-5. PubMed ID: 20154429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention.
    Uysal Y; Wolters B; Knop C; Reinehr T
    Clin Nutr; 2014 Aug; 33(4):620-5. PubMed ID: 24075648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.
    Tomazic J; Karner P; Vidmar L; Maticic M; Sharma PM; Janez A
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):99-105. PubMed ID: 16200335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical health--a cluster randomized controlled lifestyle intervention among persons with a psychiatric disability and their staff.
    Forsberg KA; Björkman T; Sandman PO; Sandlund M
    Nord J Psychiatry; 2008; 62(6):486-95. PubMed ID: 18843564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a long-term lifestyle intervention program with Mediterranean diet and exercise for the management of patients with metabolic syndrome in a primary care setting.
    Gomez-Huelgas R; Jansen-Chaparro S; Baca-Osorio AJ; Mancera-Romero J; Tinahones FJ; Bernal-López MR
    Eur J Intern Med; 2015 Jun; 26(5):317-23. PubMed ID: 25907985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of yoga exercise on serum adiponectin and metabolic syndrome factors in obese postmenopausal women.
    Lee JA; Kim JW; Kim DY
    Menopause; 2012 Mar; 19(3):296-301. PubMed ID: 22089179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
    Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A
    Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome.
    Srinivasa S; Wong K; Fitch KV; Wei J; Petrow E; Cypess AM; Torriani M; Grinspoon SK
    Clin Endocrinol (Oxf); 2015 May; 82(5):678-85. PubMed ID: 25130061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndrome.
    Belcaro G; Cornelli U; Luzzi R; Cesarone MR; Dugall M; Feragalli B; Errichi S; Ippolito E; Grossi MG; Hosoi M; Cornelli M; Gizzi G
    Phytother Res; 2013 Oct; 27(10):1572-8. PubMed ID: 23359520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive web-based lifestyle intervention and metabolic syndrome: findings from the Red Ruby (a randomized controlled trial).
    Jahangiry L; Shojaeizadeh D; Abbasalizad Farhangi M; Yaseri M; Mohammad K; Najafi M; Montazeri A
    Trials; 2015 Sep; 16():418. PubMed ID: 26390998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an eight-week supervised, structured lifestyle modification programme on anthropometric, metabolic and cardiovascular risk factors in severely obese adults.
    Crowe C; Gibson I; Cunningham K; Kerins C; Costello C; Windle J; O Shea PM; Hynes M; McGuire B; Kilkelly K; Griffin H; O Brien T; Jones J; Finucane FM
    BMC Endocr Disord; 2015 Aug; 15():37. PubMed ID: 26231181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.